ZyVersa

YTD

ALL

Why Robinhood?

You can watch ZyVersa and buy or sell other stocks, ETFs, and their options commission-free!

About ZVSA

ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It leverages advanced & proprietary technologies to develop product candidates in the areas of renal and inflammatory diseases.

CEO

Stephen C. Glover

CEOStephen C. Glover

Employees

Employees14

Headquarters

Weston, Florida

HeadquartersWeston, Florida

Founded

2014

Founded2014

Employees

Employees14

ZVSA Key Statistics

Market cap

13.55M

Market cap13.55M

Price-Earnings ratio

-0.37

Price-Earnings ratio-0.37

Dividend yield

—

Dividend yield—

Average volume

3.39M

Average volume3.39M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$523.25

52 Week high$523.25

52 Week low

$1.89

52 Week low$1.89

People also own

Based on the portfolios of people who own ZVSA. This list is generated using Robinhood data, and it’s not a recommendation.